Compounds > n(4)-hydroxycytidine
Page last updated: 2024-09-05

n(4)-hydroxycytidine and 4-amino-1-(3,4-dihydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidin-2(1h)-one

n(4)-hydroxycytidine has been researched along with 4-amino-1-(3,4-dihydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidin-2(1h)-one in 1 studies

Compound Research Comparison

Studies
(n(4)-hydroxycytidine)		Trials
(n(4)-hydroxycytidine)		Recent Studies (post-2010)
(n(4)-hydroxycytidine)		Studies
(4-amino-1-(3,4-dihydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidin-2(1h)-one)		Trials
(4-amino-1-(3,4-dihydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidin-2(1h)-one)		Recent Studies (post-2010) (4-amino-1-(3,4-dihydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidin-2(1h)-one)
42132604

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barclay, L; Costantini, VP; Lee, D; McBrayer, TR; Schinazi, RF; Vinjé, J; Whitaker, T1

Other Studies

1 other study(ies) available for n(4)-hydroxycytidine and 4-amino-1-(3,4-dihydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidin-2(1h)-one

ArticleYear
Antiviral activity of nucleoside analogues against norovirus.
    Antiviral therapy, 2012, Volume: 17, Issue:6

    Topics: Animals; Antiviral Agents; Cell Line, Tumor; Cytidine; Deoxycytidine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Gastroenteritis; Humans; Lamivudine; Mice; Norovirus; Ribavirin; RNA, Viral; Time Factors; Virus Replication

2012